TEST BANK
Pharmacology and the Nursing Process 11th Edition by Linda Lane Lilley PhD
RN, Shelly Rainforth Collins PharmD BCGP, Julie S. Snyder MSN RN MEDSURG-BC
(2025) || CURRENT EDITION
,table of contents
part 1: pharmacology basics .............................................................................5
chapter 01: the nursing process and drug therapy................................................................................... 5
chapter 02: pharmacologic principles....................................................................................................... 9
chapter 03: lifespan considerations ........................................................................................................ 16
chapter 04: cultural, legal, and ethical considerations ........................................................................... 24
chapter 05: medication errors: preventing and responding .................................................................. 31
chapter 06: patient education and drug therapy ................................................................................... 35
chapter 07: over-the-counter drugs and herbal and dietary supplements ............................................ 41
chapter 08: gene therapy and pharmacogenomics ................................................................................ 46
chapter 09: photo atlas of drug administration...................................................................................... 51
part 2: drugs affecting the central nervous systenm ...................................... 62
chapter 10: analgesic drugs .................................................................................................................... 62
chapter 11: general and local anesthetics .............................................................................................. 70
chapter 12: central nervous system depressants and muscle relaxants ................................................ 75
chapter 13: central nervous system stimulants and related drugs ........................................................ 81
chapter 14: antiepileptic drugs ............................................................................................................... 87
chapter 15: antiparkinson drugs ............................................................................................................. 93
chapter 16: psychotherapeutic drugs ..................................................................................................... 99
chapter 17: substance use disorder ...................................................................................................... 107
part 3: drugs affecting the autonomic nervous system ................................ 113
chapter 18: adrenergic drugs ................................................................................................................ 113
chapter 19: adrenergic-blocking drugs ................................................................................................. 119
chapter 20: cholinergic drugs ............................................................................................................... 125
chapter 21: cholinergic-blocking drugs ................................................................................................. 131
part 4: drugs affecting the cardiovascular and renal systems ..................... 137
chapter 22: antihypertensive drugs ...................................................................................................... 137
chapter 23: antianginal drugs ............................................................................................................... 144
chapter 24: heart failure drugs ............................................................................................................. 151
chapter 25: antidysrhythmic drugs ....................................................................................................... 157
chapter 26: coagulation modifier drugs ............................................................................................... 164
chapter 27: antilipemic drugs ............................................................................................................... 171
chapter 28: diuretic drugs ..................................................................................................................... 177
, chapter 29: fluids and electrolytes ....................................................................................................... 184
part 5: drugs affecting the endocrine and reproductive systems ................. 191
chapter 30: pituitary drugs ................................................................................................................... 191
chapter 31: thyroid and antithyroid drugs ........................................................................................... 195
chapter 32: antidiabetic drugs .............................................................................................................. 201
chapter 33: adrenal drugs ..................................................................................................................... 212
chapter 34: women’s health drugs ....................................................................................................... 217
chapter 35: men’s health drugs ............................................................................................................ 225
part 6: drugs affecting the respiratory system.............................................. 231
chapter 36: antihistamines, decongestants, antitussives, and expectorants ....................................... 231
chapter 37: respiratory drugs ............................................................................................................... 237
part 7: antiinfective and antiinflammatory drugs .......................................... 243
chapter 38: antibiotics part 1 ................................................................................................................ 244
chapter 39: antibiotics part 2 ................................................................................................................ 252
chapter 40: antiviral drugs .................................................................................................................... 258
chapter 41: antitubercular drugs .......................................................................................................... 264
chapter 42: antifungal drugs ................................................................................................................. 269
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs ......................................................... 275
chapter 44: anti-inflammatory and antigout drugs .............................................................................. 280
part 8: chemotherapeutic drugs and biologic and immune modifiers........... 287
chapter 45: antineoplastic drugs part 1: cancer overview and cell cycle-specific drugs ...................... 287
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and miscellaneous drugs ........ 294
chapter 47: biologic response–modifying and antirheumatic drugs .................................................... 299
chapter 48: immunosuppressant drugs ................................................................................................ 305
chapter 49: immunizing drugs .............................................................................................................. 311
part 9: drugs affecting the gastrointestinal system and nutrition ................ 317
chapter 50: acid-controlling drugs ........................................................................................................ 317
chapter 51: bowel disorder drugs ......................................................................................................... 324
chapter 52: antiemetic and antinausea drugs ...................................................................................... 333
chapter 53: vitamins and minerals ....................................................................................................... 339
chapter 54: anemia drugs ..................................................................................................................... 345
chapter 55: nutritional supplements .................................................................................................... 354
,part 10: dermatologic, ophthalmic, and otic drugs ....................................... 359
chapter 56: dermatologic drugs ............................................................................................................ 359
chapter 57: ophthalmic drugs ............................................................................................................... 366
chapter 58: otic drugs ........................................................................................................................... 372
,part 1: pharmacology basics
chapter 01: the nursing process and drug therapy
multiple choice
1. the nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. identification of human needs statements occur with which of these activities?
a. collection of patient data
b. administering interventions
c. deciding on patient outcomes
d. documenting the patient’s behavior
Accurate answer: a
identification of human needs occurs with the collection of patient data.
dif: cognitive level: understanding (comprehension) top: nursing process: human needs statement
msc: nclex: safe and effective care environment: management of care
2. the patient is to receive oral guaifenesin (mucinex) twice a day. today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. what type of problem does this
represent?
a. “right time”
b. “right dose”
c. “right route”
d. “right medication”
Accurate answer: a
“right time” is correct because the medication was given more than 30 minutes after the scheduled dose
was due. “dose” is incorrect because the dose is not related to the time the medication administration is
scheduled. “route” is incorrect because the route is not affected. “medication” is incorrect because the
medication ordered will not change.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: safety and infection control
, 3. the nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. which phase of the nursing
process do these actions illustrate?
a. human needs statement
b. planning
c. implementation
d. evaluation
Accurate answer: d
monitoring the patient’s progress, including the patient’s response to the medication, is part of the
evaluation phase. planning, implementation, and human needs statement are not illustrated by this
example.
dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
msc: nclex: safe and effective care environment: management of care
4. the nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. which
statement best illustrates an outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient will adhere to the new insulin treatment regimen.
d. the patient will demonstrate correct blood glucose testing technique.
Accurate answer: d
“demonstrating correct blood glucose testing technique” is a specific and measurable outcome criterion.
“following instructions” and “not experiencing complications” are not specific criteria. “adhering to new
regimen” would be difficult to measure.
dif: cognitive level: applying (application) top: nursing process: planning
msc: nclex: safe and effective care environment: management of care
5. which activity best reflects the implementation phase of the nursing process for the patient who
is newly diagnosed with hypertension?
a. providing education on keeping a journal of blood pressure readings
b. setting goals and outcome criteria with the patient’s input
Pharmacology and the Nursing Process 11th Edition by Linda Lane Lilley PhD
RN, Shelly Rainforth Collins PharmD BCGP, Julie S. Snyder MSN RN MEDSURG-BC
(2025) || CURRENT EDITION
,table of contents
part 1: pharmacology basics .............................................................................5
chapter 01: the nursing process and drug therapy................................................................................... 5
chapter 02: pharmacologic principles....................................................................................................... 9
chapter 03: lifespan considerations ........................................................................................................ 16
chapter 04: cultural, legal, and ethical considerations ........................................................................... 24
chapter 05: medication errors: preventing and responding .................................................................. 31
chapter 06: patient education and drug therapy ................................................................................... 35
chapter 07: over-the-counter drugs and herbal and dietary supplements ............................................ 41
chapter 08: gene therapy and pharmacogenomics ................................................................................ 46
chapter 09: photo atlas of drug administration...................................................................................... 51
part 2: drugs affecting the central nervous systenm ...................................... 62
chapter 10: analgesic drugs .................................................................................................................... 62
chapter 11: general and local anesthetics .............................................................................................. 70
chapter 12: central nervous system depressants and muscle relaxants ................................................ 75
chapter 13: central nervous system stimulants and related drugs ........................................................ 81
chapter 14: antiepileptic drugs ............................................................................................................... 87
chapter 15: antiparkinson drugs ............................................................................................................. 93
chapter 16: psychotherapeutic drugs ..................................................................................................... 99
chapter 17: substance use disorder ...................................................................................................... 107
part 3: drugs affecting the autonomic nervous system ................................ 113
chapter 18: adrenergic drugs ................................................................................................................ 113
chapter 19: adrenergic-blocking drugs ................................................................................................. 119
chapter 20: cholinergic drugs ............................................................................................................... 125
chapter 21: cholinergic-blocking drugs ................................................................................................. 131
part 4: drugs affecting the cardiovascular and renal systems ..................... 137
chapter 22: antihypertensive drugs ...................................................................................................... 137
chapter 23: antianginal drugs ............................................................................................................... 144
chapter 24: heart failure drugs ............................................................................................................. 151
chapter 25: antidysrhythmic drugs ....................................................................................................... 157
chapter 26: coagulation modifier drugs ............................................................................................... 164
chapter 27: antilipemic drugs ............................................................................................................... 171
chapter 28: diuretic drugs ..................................................................................................................... 177
, chapter 29: fluids and electrolytes ....................................................................................................... 184
part 5: drugs affecting the endocrine and reproductive systems ................. 191
chapter 30: pituitary drugs ................................................................................................................... 191
chapter 31: thyroid and antithyroid drugs ........................................................................................... 195
chapter 32: antidiabetic drugs .............................................................................................................. 201
chapter 33: adrenal drugs ..................................................................................................................... 212
chapter 34: women’s health drugs ....................................................................................................... 217
chapter 35: men’s health drugs ............................................................................................................ 225
part 6: drugs affecting the respiratory system.............................................. 231
chapter 36: antihistamines, decongestants, antitussives, and expectorants ....................................... 231
chapter 37: respiratory drugs ............................................................................................................... 237
part 7: antiinfective and antiinflammatory drugs .......................................... 243
chapter 38: antibiotics part 1 ................................................................................................................ 244
chapter 39: antibiotics part 2 ................................................................................................................ 252
chapter 40: antiviral drugs .................................................................................................................... 258
chapter 41: antitubercular drugs .......................................................................................................... 264
chapter 42: antifungal drugs ................................................................................................................. 269
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs ......................................................... 275
chapter 44: anti-inflammatory and antigout drugs .............................................................................. 280
part 8: chemotherapeutic drugs and biologic and immune modifiers........... 287
chapter 45: antineoplastic drugs part 1: cancer overview and cell cycle-specific drugs ...................... 287
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and miscellaneous drugs ........ 294
chapter 47: biologic response–modifying and antirheumatic drugs .................................................... 299
chapter 48: immunosuppressant drugs ................................................................................................ 305
chapter 49: immunizing drugs .............................................................................................................. 311
part 9: drugs affecting the gastrointestinal system and nutrition ................ 317
chapter 50: acid-controlling drugs ........................................................................................................ 317
chapter 51: bowel disorder drugs ......................................................................................................... 324
chapter 52: antiemetic and antinausea drugs ...................................................................................... 333
chapter 53: vitamins and minerals ....................................................................................................... 339
chapter 54: anemia drugs ..................................................................................................................... 345
chapter 55: nutritional supplements .................................................................................................... 354
,part 10: dermatologic, ophthalmic, and otic drugs ....................................... 359
chapter 56: dermatologic drugs ............................................................................................................ 359
chapter 57: ophthalmic drugs ............................................................................................................... 366
chapter 58: otic drugs ........................................................................................................................... 372
,part 1: pharmacology basics
chapter 01: the nursing process and drug therapy
multiple choice
1. the nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. identification of human needs statements occur with which of these activities?
a. collection of patient data
b. administering interventions
c. deciding on patient outcomes
d. documenting the patient’s behavior
Accurate answer: a
identification of human needs occurs with the collection of patient data.
dif: cognitive level: understanding (comprehension) top: nursing process: human needs statement
msc: nclex: safe and effective care environment: management of care
2. the patient is to receive oral guaifenesin (mucinex) twice a day. today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. what type of problem does this
represent?
a. “right time”
b. “right dose”
c. “right route”
d. “right medication”
Accurate answer: a
“right time” is correct because the medication was given more than 30 minutes after the scheduled dose
was due. “dose” is incorrect because the dose is not related to the time the medication administration is
scheduled. “route” is incorrect because the route is not affected. “medication” is incorrect because the
medication ordered will not change.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: safety and infection control
, 3. the nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. which phase of the nursing
process do these actions illustrate?
a. human needs statement
b. planning
c. implementation
d. evaluation
Accurate answer: d
monitoring the patient’s progress, including the patient’s response to the medication, is part of the
evaluation phase. planning, implementation, and human needs statement are not illustrated by this
example.
dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
msc: nclex: safe and effective care environment: management of care
4. the nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. which
statement best illustrates an outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient will adhere to the new insulin treatment regimen.
d. the patient will demonstrate correct blood glucose testing technique.
Accurate answer: d
“demonstrating correct blood glucose testing technique” is a specific and measurable outcome criterion.
“following instructions” and “not experiencing complications” are not specific criteria. “adhering to new
regimen” would be difficult to measure.
dif: cognitive level: applying (application) top: nursing process: planning
msc: nclex: safe and effective care environment: management of care
5. which activity best reflects the implementation phase of the nursing process for the patient who
is newly diagnosed with hypertension?
a. providing education on keeping a journal of blood pressure readings
b. setting goals and outcome criteria with the patient’s input
